[Press Release]MFDS Opens a New Era of Innovation in Medical Product Approval and Review(Target: 240-Day Approval)
- Registration Date 2026-05-28
- Hit 979
[Press Release]MFDS Opens a New Era of Innovation in Medical Product Approval and Review(Target: 240-Day Approval)
Follow-up to President-Chaired Regulatory Rationalization Committee
Approval and Review Innovation Grants Korean Citizens the Fastest Access to Medical Treatments in the World
New Expedited Approval and Review Process for New Drugs, Biosimilars, and Innovative Medical Devices Takes Effect June 1
Division 규제과학정책추진단
Written by 나지이
Telephone 043-719-1385